Literature DB >> 23229760

Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro.

Zhi Li Liu1, Jian Hua Mao, Ai Fen Peng, Qing Shui Yin, Yang Zhou, Xin Hua Long, Shan Hu Huang.   

Abstract

In the present study, the effect of fatty acid synthase (FASN) inhibition on cell invasion and migration in vitro was investigated. A recombinant plasmid containing a microRNA targeting the FASN gene was used to inhibit FASN expression in U2‑OS cells. Cell migration and invasion were investigated using wound healing and Transwell invasion assays. We found that cell invasion and migration were suppressed by inhibiting FASN. In addition, the effect of inhibition of FASN on phosphorylation of Akt was investigated by detecting the expression levels of pAkt using western blot analysis. Furthermore, protein expression levels of nuclear factor‑κB (NF‑κB; p65) and matrix metalloproteinase (MMP)‑2 and ‑9 were also measured by western blot analysis. Results demonstrated that expression levels of pAkt, NF‑κB (p65) and MMP‑2 and ‑9 proteins were reduced significantly by inhibiting FASN. Therefore, we confirmed that inhibition of FASN by RNA interference suppresses osteosarcoma cell metastasis via downregulation of the phosphoinositide 3‑kinase/Akt/NF‑κB signaling pathway in vitro.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229760     DOI: 10.3892/mmr.2012.1220

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  16 in total

1.  Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.

Authors:  Lei Li; Giulia M Pilo; Xiaolei Li; Antonio Cigliano; Gavinella Latte; Li Che; Christy Joseph; Marta Mela; Chunmei Wang; Lijie Jiang; Silvia Ribback; Maria M Simile; Rosa M Pascale; Frank Dombrowski; Matthias Evert; Clay F Semenkovich; Xin Chen; Diego F Calvisi
Journal:  J Hepatol       Date:  2015-10-22       Impact factor: 25.083

2.  Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.

Authors:  Ga Bin Park; Daejin Kim
Journal:  Mol Cell Biochem       Date:  2017-08-17       Impact factor: 3.396

3.  De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.

Authors:  Naser Jafari; James Drury; Andrew J Morris; Fredrick O Onono; Payton D Stevens; Tianyan Gao; Jinpeng Liu; Chi Wang; Eun Y Lee; Heidi L Weiss; B Mark Evers; Yekaterina Y Zaytseva
Journal:  Mol Cancer Res       Date:  2018-08-28       Impact factor: 5.852

4.  Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.

Authors:  Xin Hua Long; Kai Zhao; Guo Mei Zhang; Yang Zhou; Rong Ping Zhou; Zhi Li Liu; Zhi Hong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

5.  Tanshinone IIA Inhibits Osteosarcoma Growth through a Src Kinase-Dependent Mechanism.

Authors:  Chao Hu; Xiaobin Zhu; Taogen Zhang; Zhouming Deng; Yuanlong Xie; Feifei Yan; Lin Cai
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

6.  Blocking fatty acid synthase inhibits tumor progression of human osteosarcoma by regulating the human epidermal growth factor receptor 2/phosphoinositide 3-kinase/protein kinase B signaling pathway in xenograft models.

Authors:  Xuan Yin Chen; Hui Bing Ruan; Xin Hua Long; Ai Fen Peng; Long Dian Zhou; Jia Ming Liu; Yang Zhou; Zhi Li Liu
Journal:  Exp Ther Med       Date:  2017-03-29       Impact factor: 2.447

7.  A New Paradigm to Mitigate Osteosarcoma by Regulation of MicroRNAs and Suppression of the NF-κB Signaling Cascade.

Authors:  Raj Kumar Mongre; Simrinder Singh Sodhi; Mrinmoy Ghosh; Jeong Hyun Kim; Nameun Kim; Neelesh Sharma; Dong Kee Jeong
Journal:  Dev Reprod       Date:  2014-12

8.  Transcription factor NF‑YA promotes a malignant phenotype by upregulating fatty acid synthase expression.

Authors:  Jing Guo; Ling Min Kong; Ai Fen Peng; Xin Hua Long; Yang Zhou; Yong Shu
Journal:  Mol Med Rep       Date:  2016-10-27       Impact factor: 2.952

9.  Endothelin A receptor antagonism enhances inhibitory effects of anti-ganglioside GD2 monoclonal antibody on invasiveness and viability of human osteosarcoma cells.

Authors:  Bo Liu; Yi Wu; Yu Zhou; Dan Peng
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

10.  Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells.

Authors:  Lei Wu; Liang Yang; Yu Xiong; Hua Guo; Xiaoli Shen; Zujue Cheng; Yan Zhang; Ziyun Gao; Xingen Zhu
Journal:  Tumour Biol       Date:  2014-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.